HIV genotyping provides susceptibility information for integrase inhibitors (INI). Intended for patients with viral load >500 copies/mL.
- Patient Preparation
- Collect
- Lavender (EDTA), pink (K2EDTA), or plasma preparation tube.
- Specimen Preparation
- Separate plasma from cells within 6 hours. Transfer 4 mL plasma to an ARUP Standard Transport Tube. (Min: 1.5 mL)
- Storage/Transport Temperature
- Frozen.
- Unacceptable Conditions
- Serum. Heparinized specimens.
- Remarks
- Please submit most recent viral load and test date, if available.
- Stability
- On cells: Ambient: 6 hours; After separation from cells: Ambient: 24 hours; Refrigerated: 5 days; Frozen: 4 months
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
2004458 | HIV-1 Integrase Inhib. Resistance, Seq | 72560-6 |
- HIV Drug Resistance
- HIV Integrase Genotype
- HIV Integrase Inhibitor Resistance
- HIV Treatment Susceptibility Testing
- HIV1 Integrase Resistance
- HIV1 Integrase Sequencing
- HIV1 Sequencing
- Raltegravir (Isentress(TM)) Resistance